Abstract Submission ACSCD is looking forward to receiving your abstracts for the 2021 African Congress on Sickle Cell Disease to be held in Virtually, from 25 - 29 May 2021. The deadline for submissions is Friday 19 March 2021 at 23:59 WAT. Contact Information First Name: * Last Name: * Email: * Phone: * please add (+ country code) Organization: * City * State/Region/Province Zip/Postal Code Country * —Please choose an option—Nigeria---AfghanistanAlbaniaAlgeriaAndorraAngolaAntigua and BarbudaArgentinaArmeniaAustraliaAustriaAzerbaijanThe BahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBruneiBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCentral African RepublicChadChileChinaColombiaComorosCongo, Democratic Republic of theCongo, Republic of theCosta RicaCôte d’IvoireCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEast Timor (Timor-Leste)EcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFijiFinlandFranceGabonThe GambiaGeorgiaGermanyGhanaGreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKiribatiKorea, NorthKorea, SouthKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMicronesia, Federated States ofMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNew ZealandNicaraguaNigerNigeriaNorth MacedoniaNorwayOmanPakistanPalauPanamaPapua New GuineaParaguayPeruPhilippinesPolandPortugalQatarRomaniaRussiaRwandaSaint Kitts and NevisSaint LuciaSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSpainSri LankaSudanSudan, SouthSurinameSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamYemenZambiaZimbabwe Submission Information Submission Type* Scientific StudyPractice, Policy and Advocacy ReportFundraising Campaign Reports Title: * Max. 200 characters. Type in lower-case letters, except for abbreviations and study names Track: * The topic track under which your abstract should be graded Track 1: Sickle Cell Prevention – Advancing Newborn Screening & Early Detection -- Choose Topic --Advances in newborn screeningRecent advances in sickle cell preventionCross-sectorial collaboration in sickle cell preventionDispelling myths and misconceptions about sickle cellEarly detectionEconomics of sickle cell preventionEducation in sickle cell preventionEpidemiologyEquity and sickle cell preventionE-technologyEthics in sickle cell prevention and screeningEvidence to practice – successes and gapsReproduction policyHealth promotionInterventions for disadvantaged populationsLaw and policy making in sickle cell preventionSickle cell prevention strategiesMeasurement and monitoring of risk behaviorsPatient advocacyPolicy development in sickle cell preventionPrevention in partnershipPrograms and policies on genotype testingRisk factorsScreening and early detection: program implementationScreening and early detection: recruitment and communicationScreening and early detection: technological advancesSickle cell prevention & control – international efforts and new strategiesUsing media to achieve public health objectivesWellness at work Track 2: Sickle Cell Diagnosis, Complications and Treatment – Addressing barriers & Inequality in Sickle Cell Care -- Choose Topic--Access to careSickle cell classificationClinical advances in diagnosisClinical advances in treatmentClinical advances in pain managementCost of sickle cell treatmentEarly diagnosis and optimizing treatmentEssential medicinesEthical consideration in sickle cell careHealth technology assessmentInequities in sickle cell careM-health for diagnosisPediatric carePersonalized therapiesQuality of sickle cell care Track 3: Maximizing Quality of Life – Empowering Patients & Caregivers -- Choose Topic --Access to pain relief/managementAdvance sickle cell – specific issuesAdvanced care planningSickle cell and well-beingSickle cell management, care and financial impactCare giversCaring for patients with co-morbidityCommunity engagement in advocacyDelivery of health informationEmpower sickle cell patientsEthics of access to sickle cell careEthics of clinical researchGlobal perceptions of sickle cellHealth systems and palliative care / pain managementImproving care deliveryImproving support outcomesDelivery of psycho-social support to patients and care giversInnovation and technology in careLack of healthcare workersLaw and patient careMedia and advocacy for pain reliefPediatric sickle cell pain management and palliative carePain and symptom assessment and managementPatient and family experiencePatient and family supportPatient safetyPsycho-social studies and interventions in sickle cell careQuality of life in palliative careSexuality issues brought by sickle cellReproductive issues brought by sickle cellSupportive careSupportive care in the resource poor settingSustainable models of care Track 4: Advocacy, Policies and Enabling Sustainable Outcomes of Healthcare Systems -- Choose Topic --Application of sickle cell evidence / implementation science measuresSickle cell management and control planning in low and middle income countriesSickle cell registries and their potential impact on sickle cell management & control planning and evaluationCost of sickle cell diseaseCross sector collaboration to make systems change / strengthen systemsEconomics of strengthening health systems for sickle cell diseaseEffective national sickle cell control planningEmpowering national networks for global changeFunding sickle cell research – fund allocationGlobal capacity and capability for health professionalsGlobal education and training initiatives: building stronger networksHealth technology assessment systems and their impactChallenges and Impact of national sickle cell screening programImproving international healthcare systems for early sickle cell diagnosis and survivalIntegrating sickle cell and NCDs into existing services, health systems strengthening, and patient empowermentIntegration of new technologies into sickle cell control strategiesLegal strategiesDataPatient empowermentPatient rightsPerformance modelsQuality modelsRole of Governments in sickle cell controlRole of NGOs and civil societies in sickle cell controlRole of private sector in sickle cell controlRole of Media in sickle cell controlStrategies to engage indigenous communities in achieving culturally responsive sickle cell care servicesSustainable access to innovative sickle cell medicineSystems for community involvement Track 5: Cross-sector Partnering and Building Capacities – Raising funds & Attracting Resources -- Choose Topic --Developing platforms for multi-sectoral dialogueDeveloping the next generation of sickle cell researchers and leadersEducation and training initiativesBuilding and sustaining high quality partnerships with patientsBuilding capacity in monitoring & evaluationCreating effective private and public sector partnershipsEffective financial management of NGOsEffective leadership models for NGOs / improved GovernanceEmpowering patients and sickle cell caregivers with information and trainingEnabling knowledge transfer of sickle cell control resourcesEngaging non-traditional partners across diseases and sectorsEssential skills for developing successful sickle cell advocacy strategiesHow to approach and work with the GovernmentImplementing effective research strategies and communicating outcomesInnovative fundraising modelsManaging conflict of interestMobilizing international networksSuccessful communication strategies and leveraging social mediaWorking with volunteers COVID-19 and Sickle Cell Disease * Does your abstract submission relate to COVID-19? YesNo Presentation Preference * -- Choose --Virtual Abstract SessionVirtual ePoster Author Information On Behalf Of * Is your abstract being presented on behalf of colleagues who are described as a group (‘the xxx Trial Investigators’ or ‘The xxx Collaborators’ or similar)? YesNo Group Name * insert the group name in the box. If there are two study groups you can also indicate this ('on behalf of the xxx Investigators and the xxx Collaborators’) x Do not list any author names in this field Authors * The Presenter must be included in the authors list and be the first author in the list. x 5 presentations maximum per presenter. Author #{{author_index}} Title: * Select...Assistant ProfessorAssociate ProfessorDoctorMissMrMrsMsProfessorSirUnknown Initials: * Last Name: * Email: * Date of Birth: * Student Author Affiliation Institution/Organization: * Department: If you would like your department to be listed please specify above City: * Country: * Add AuthorRemove Author Abstract Information Background and Objective * Please enter your text in the text area below. You may compile the abstract body by copy and paste text. Method * Please enter your text in the text area below. You may compile the abstract body by copy and paste text. Results * Please enter your text in the text area below. You may compile the abstract body by copy and paste text. Conclusion * Please enter your text in the text area below. You may compile the abstract body by copy and paste text. Keywords Separate keywords with commas Disclosure Please disclose all conflict of interests for any author of this abstract. Upload Abstract File All proposals must be submitted by file upload in one of the following formats: - Microsoft Word Office Open XML Format (.docx). Older .doc formats no longer supported - Portable Document Format (.pdf). If your submission file is in another format, you can convert it to .docx format at the following link: https://convertio.co/convert-to-docx/ Upload Abstract * Because proposals are subject to blind review, please do not include the author name(s) in this file upload. If your paper is accepted for presentation, you will be asked to submit a new version with author names included. Size limit: 5mb, Formats: .docx Affirmations * Please read all items carefully and click "I agree". You will not be able to complete your submission without having agreed with all mandatory items. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted. Submission of the abstract constitutes the consent of all authors to publication (e.g. Congress website, programs, other promotions, etc.) The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the "Content") to ACSCD 2021 and Dr. SickleCell (Hereafter: the "Organizers"), nor the publication of any such Content by the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights. The Abstract Submitter grants the Organizers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable nonexclusive basis. I herewith confirm that the contact details sent in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on abstract correspondence. I understand that the presenting author must be a registered participant. The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the above. I understand that I must select a specific Theme track, Topic and/or Sub-Topic for my abstract allocation. Although the Committee will work hard to honor this selection, this cannot be guaranteed. The Committee reserves the right to change the Theme track, Topic or Sub-Topic under which the abstract was originally submitted. I agree (mandatory) By submitting this abstract, you agree to attend the congress event and consent to the display and usage of your submitted materials for the necessary activities to facilitate the success of this congress. [submission_code] SUBMIT ABSTRACT